Cinclus Pharma Holding Ab
Clinical trials sponsored by Cinclus Pharma Holding Ab, explained in plain language.
-
New heartburn drug aims to outperform standard treatment in major trial
Disease control Not yet recruitingThis study is testing whether a new medication called linaprazan glurate works better than the commonly used drug lansoprazole at keeping the esophagus healed in people with acid reflux disease (GERD). About 1050 adults who have already had their esophagus damage healed in a prev…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill aims to outperform standard heartburn drug in healing damaged esophagus
Disease control Not yet recruitingThis study is testing if a new drug called linaprazan glurate works better than the common medication lansoprazole at healing damage in the esophagus caused by severe acid reflux (GERD). About 500 adults with confirmed esophageal damage will be randomly assigned to take one of tw…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC